Chromosome translocations: dangerous liaisons revisited

Although it has been clear for more than a century that the chromosomes in human tumour cells are often wildly abnormal, there has been controversy as to whether these changes are primary events or are merely secondary epiphenomena that reflect the genomic instability of these cells. The prevailing view for most of this period was that chromosome changes were secondary events. What happened to change this view?

[1]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[2]  N. Heerema,et al.  Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. , 1998, Blood.

[3]  T. Rabbitts,et al.  Chromosomal abnormalities in lymphoid tumours: mechanism and role in tumour pathogenesis. , 1988, Trends in genetics : TIG.

[4]  F. Oski,et al.  Hematology of Infancy and Childhood , 1974 .

[5]  J. Rowley,et al.  Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. , 1979, Cancer research.

[6]  G. Klein,et al.  Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas , 1976, International journal of cancer.

[7]  D. Baltimore,et al.  Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine , 1980, Nature.

[8]  R. Berger,et al.  Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects. , 1990, Cancer genetics and cytogenetics.

[9]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[10]  F. Mittelman.  The Third International Workshop on Chromosomes in Leukemia. Lund, Sweden, July 21-25, 1980. Introduction. , 1981, Cancer genetics and cytogenetics.

[11]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Stanulla,et al.  DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis , 1997, Molecular and cellular biology.

[13]  J. Teruya-Feldstein,et al.  Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. , 2000, Seminars in hematology.

[14]  P. Leder,et al.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Rowley,et al.  AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. , 1995, Blood.

[16]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[17]  M. Moore.  The clinical use of colony stimulating factors. , 1991, Annual review of immunology.

[18]  A. Levan.  Some current problems of cancer cytogenetics. , 2009, Hereditas.

[19]  D. Baltimore,et al.  A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product , 1979, Nature.

[20]  J Erikson,et al.  Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. , 1983, Science.

[21]  P. Nilsson,et al.  Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. , 1981, Cancer genetics and cytogenetics.

[22]  C. Bloomfield,et al.  Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[23]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[24]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[25]  M. Freedman,et al.  Fusion Between Transcription Factor CBFP/PEBP2I3 andaMyosin HeavyChain in AcuteMyeloid Leukemia , 1993 .

[26]  R. Larson,et al.  Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. , 1983, The New England journal of medicine.

[27]  Rowley Jd.  Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. , 1973 .

[28]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[29]  N. Heisterkamp,et al.  Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia , 1987, Cell.

[30]  G. Daley,et al.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.

[31]  A. Sandberg.  Second International Workshop on Chromosomes in Leukemia. , 1980, Cancer research.

[32]  F. Mitelman,et al.  Catalog of Chromosome Aberrations in Cancer , 1996, British Journal of Cancer.

[33]  J. Rowley,et al.  Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas , 1977 .

[34]  S. Korsmeyer,et al.  Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.

[35]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[36]  C. Bloomfield,et al.  Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[37]  Theodor Boveri.  Zur Frage der Entstehung maligner Tumoren , 1914 .

[38]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.

[39]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[40]  T. Glover.  Catalog of chromosome aberrations in cancer, 4th ed , 1992 .

[41]  C. Sawyers,et al.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[42]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[43]  J. Birch.  Genes and cancer , 1999, Archives of disease in childhood.

[44]  F. Alt,et al.  The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.

[45]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[46]  N. Zhao,et al.  Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Lilleyman.  Hematology of Infancy and Childhood , 1993 .

[48]  B. Roe,et al.  DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. , 2000, Human molecular genetics.

[49]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[50]  C. Croce,et al.  A common mechanism of chromosomal translocation in T- and B-cell neoplasia. , 1986, Science.

[51]  J. Stephenson,et al.  Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia , 1983, Nature.

[52]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[53]  C. Croce,et al.  Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia. , 1995, JAMA.

[54]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[55]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .

[56]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.